Development of a Microscopic Colitis Disease Activity Index: A prospective cohort study

Thomas G. Cotter, Moritz Binder, Edward Vincent Loftus, Jr, Rami Abboud, Meredythe A. McNally, Thomas Christopher Smyrk, William J. Tremaine, William J. Sandborn, Darrell S. Pardi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective Microscopic colitis (MC) is a common cause of chronic diarrhoea, often with additional symptoms. No validated instruments exist to assess disease activity in MC, making it difficult to compare efficacy of treatments between clinical trials. We aimed to identify clinical features that independently predicted disease severity and create a Microscopic Colitis Disease Activity Index (MCDAI). Design Patients with MC were prospectively administered a survey assessing their GI symptoms and the IBD Questionnaire (IBDQ). A single investigator also scored a physician global assessment (PGA) of disease severity on a 10-point scale. Multiple linear regression identified which symptoms best predicted the PGA. These symptoms were then combined in a weighted formula to create the MCDAI. The relationship between MCDAI and the IBDQ was investigated. Results Of the 175 patients enrolled, 13 (7.4%) did not complete the survey. The remaining 162 had a median age of 66 years (range, 57-73) and 74% were female. Several clinical features were independently associated with PGA (number of unformed stools daily, presence of nocturnal stools, abdominal pain, weight loss, faecal urgency and faecal incontinence). These parameters were combined to create the MCDAI, which strongly predicted the PGA (R2=0.80). A 1-unit decrease in disease activity (δMCDAI) was associated with a 9-unit increase in quality of life (δIBDQ). Conclusions The MCDAI strongly predicted the PGA and correlated with a validated measure of quality of life. Several symptoms in addition to diarrhoea are associated with disease severity in MC.

Original languageEnglish (US)
JournalGut
DOIs
StateAccepted/In press - Dec 13 2016

Fingerprint

Microscopic Colitis
Cohort Studies
Prospective Studies
Physicians
Diarrhea
Quality of Life
Fecal Incontinence
Abdominal Pain
Weight Loss

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Cotter, T. G., Binder, M., Loftus, Jr, E. V., Abboud, R., McNally, M. A., Smyrk, T. C., ... Pardi, D. S. (Accepted/In press). Development of a Microscopic Colitis Disease Activity Index: A prospective cohort study. Gut. https://doi.org/10.1136/gutjnl-2016-313051

Development of a Microscopic Colitis Disease Activity Index : A prospective cohort study. / Cotter, Thomas G.; Binder, Moritz; Loftus, Jr, Edward Vincent; Abboud, Rami; McNally, Meredythe A.; Smyrk, Thomas Christopher; Tremaine, William J.; Sandborn, William J.; Pardi, Darrell S.

In: Gut, 13.12.2016.

Research output: Contribution to journalArticle

Cotter, TG, Binder, M, Loftus, Jr, EV, Abboud, R, McNally, MA, Smyrk, TC, Tremaine, WJ, Sandborn, WJ & Pardi, DS 2016, 'Development of a Microscopic Colitis Disease Activity Index: A prospective cohort study', Gut. https://doi.org/10.1136/gutjnl-2016-313051
Cotter, Thomas G. ; Binder, Moritz ; Loftus, Jr, Edward Vincent ; Abboud, Rami ; McNally, Meredythe A. ; Smyrk, Thomas Christopher ; Tremaine, William J. ; Sandborn, William J. ; Pardi, Darrell S. / Development of a Microscopic Colitis Disease Activity Index : A prospective cohort study. In: Gut. 2016.
@article{87df433bcde044329d1928a1a0c73427,
title = "Development of a Microscopic Colitis Disease Activity Index: A prospective cohort study",
abstract = "Objective Microscopic colitis (MC) is a common cause of chronic diarrhoea, often with additional symptoms. No validated instruments exist to assess disease activity in MC, making it difficult to compare efficacy of treatments between clinical trials. We aimed to identify clinical features that independently predicted disease severity and create a Microscopic Colitis Disease Activity Index (MCDAI). Design Patients with MC were prospectively administered a survey assessing their GI symptoms and the IBD Questionnaire (IBDQ). A single investigator also scored a physician global assessment (PGA) of disease severity on a 10-point scale. Multiple linear regression identified which symptoms best predicted the PGA. These symptoms were then combined in a weighted formula to create the MCDAI. The relationship between MCDAI and the IBDQ was investigated. Results Of the 175 patients enrolled, 13 (7.4{\%}) did not complete the survey. The remaining 162 had a median age of 66 years (range, 57-73) and 74{\%} were female. Several clinical features were independently associated with PGA (number of unformed stools daily, presence of nocturnal stools, abdominal pain, weight loss, faecal urgency and faecal incontinence). These parameters were combined to create the MCDAI, which strongly predicted the PGA (R2=0.80). A 1-unit decrease in disease activity (δMCDAI) was associated with a 9-unit increase in quality of life (δIBDQ). Conclusions The MCDAI strongly predicted the PGA and correlated with a validated measure of quality of life. Several symptoms in addition to diarrhoea are associated with disease severity in MC.",
author = "Cotter, {Thomas G.} and Moritz Binder and {Loftus, Jr}, {Edward Vincent} and Rami Abboud and McNally, {Meredythe A.} and Smyrk, {Thomas Christopher} and Tremaine, {William J.} and Sandborn, {William J.} and Pardi, {Darrell S.}",
year = "2016",
month = "12",
day = "13",
doi = "10.1136/gutjnl-2016-313051",
language = "English (US)",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Development of a Microscopic Colitis Disease Activity Index

T2 - A prospective cohort study

AU - Cotter, Thomas G.

AU - Binder, Moritz

AU - Loftus, Jr, Edward Vincent

AU - Abboud, Rami

AU - McNally, Meredythe A.

AU - Smyrk, Thomas Christopher

AU - Tremaine, William J.

AU - Sandborn, William J.

AU - Pardi, Darrell S.

PY - 2016/12/13

Y1 - 2016/12/13

N2 - Objective Microscopic colitis (MC) is a common cause of chronic diarrhoea, often with additional symptoms. No validated instruments exist to assess disease activity in MC, making it difficult to compare efficacy of treatments between clinical trials. We aimed to identify clinical features that independently predicted disease severity and create a Microscopic Colitis Disease Activity Index (MCDAI). Design Patients with MC were prospectively administered a survey assessing their GI symptoms and the IBD Questionnaire (IBDQ). A single investigator also scored a physician global assessment (PGA) of disease severity on a 10-point scale. Multiple linear regression identified which symptoms best predicted the PGA. These symptoms were then combined in a weighted formula to create the MCDAI. The relationship between MCDAI and the IBDQ was investigated. Results Of the 175 patients enrolled, 13 (7.4%) did not complete the survey. The remaining 162 had a median age of 66 years (range, 57-73) and 74% were female. Several clinical features were independently associated with PGA (number of unformed stools daily, presence of nocturnal stools, abdominal pain, weight loss, faecal urgency and faecal incontinence). These parameters were combined to create the MCDAI, which strongly predicted the PGA (R2=0.80). A 1-unit decrease in disease activity (δMCDAI) was associated with a 9-unit increase in quality of life (δIBDQ). Conclusions The MCDAI strongly predicted the PGA and correlated with a validated measure of quality of life. Several symptoms in addition to diarrhoea are associated with disease severity in MC.

AB - Objective Microscopic colitis (MC) is a common cause of chronic diarrhoea, often with additional symptoms. No validated instruments exist to assess disease activity in MC, making it difficult to compare efficacy of treatments between clinical trials. We aimed to identify clinical features that independently predicted disease severity and create a Microscopic Colitis Disease Activity Index (MCDAI). Design Patients with MC were prospectively administered a survey assessing their GI symptoms and the IBD Questionnaire (IBDQ). A single investigator also scored a physician global assessment (PGA) of disease severity on a 10-point scale. Multiple linear regression identified which symptoms best predicted the PGA. These symptoms were then combined in a weighted formula to create the MCDAI. The relationship between MCDAI and the IBDQ was investigated. Results Of the 175 patients enrolled, 13 (7.4%) did not complete the survey. The remaining 162 had a median age of 66 years (range, 57-73) and 74% were female. Several clinical features were independently associated with PGA (number of unformed stools daily, presence of nocturnal stools, abdominal pain, weight loss, faecal urgency and faecal incontinence). These parameters were combined to create the MCDAI, which strongly predicted the PGA (R2=0.80). A 1-unit decrease in disease activity (δMCDAI) was associated with a 9-unit increase in quality of life (δIBDQ). Conclusions The MCDAI strongly predicted the PGA and correlated with a validated measure of quality of life. Several symptoms in addition to diarrhoea are associated with disease severity in MC.

UR - http://www.scopus.com/inward/record.url?scp=85007007017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007007017&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2016-313051

DO - 10.1136/gutjnl-2016-313051

M3 - Article

C2 - 27965284

AN - SCOPUS:85007007017

JO - Gut

JF - Gut

SN - 0017-5749

ER -